Riccardo Dolcetti

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 17

Top Venues

Cancers

International journal of molecular sciences

Clinical & translational immunology

Biomedicines

The University of Queensland

This page only lists publications with an associated author ORCID identifier.

Affiliation History

The University of Queensland Nov 17 2015

Australia

Research Chair in Cancer Medicine :: Diamantina Institute

Centro di Riferimento Oncologico Jan 01 2002 - Nov 16 2015

Italy

Head :: Cancer Bio-Immunotherapy Unit

Publications

Saranya Pounraj, Shuxiong Chen, Linlin Ma, Roberta Mazzieri, Riccardo Dolcetti, Bernd H A Rehm
Targeting tumor heterogeneity with neoantigen-based cancer vaccines. Cancer research (2023)
Charlene Waryah, Eric Alves, Roberta Mazzieri, Riccardo Dolcetti, Erik W Thompson, Andrew D Redfern, Pilar Blancafort
Unpacking the Complexity of Epithelial Plasticity: From Master Regulator Transcription Factors to Non-Coding RNAs. Cancers 15 (12) (2023)
Bijun Zeng, Davide Moi, Lynn Tolley, Natalie Molotkov, Ian Hector Frazer, Christopher Perry, Riccardo Dolcetti, Roberta Mazzieri, Jazmina L G Cruz
Skin-Grafting and Dendritic Cell "Boosted" Humanized Mouse Models Allow the Pre-Clinical Evaluation of Therapeutic Cancer Vaccines. Cells 12 (16) (2023)
María Julia Lamberti, Barbara Montico, Maria Ravo, Annunziata Nigro, Giorgio Giurato, Roberta Iorio, Roberta Tarallo, Alessandro Weisz, Cristiana Stellato, Agostino Steffan, Riccardo Dolcetti, Vincenzo Casolaro, Damiana Antonia Faè, Jessica Dal Col
Integration of miRNA:mRNA Co-Expression Revealed Crucial Mechanisms Modulated in Immunogenic Cancer Cell Death. Biomedicines 10 (8) (2022)
Priyakshi Kalita-de Croft, Haarika Chittoory, Tam H Nguyen, Jodi Marie Saunus, Woo Gyeong Kim, Amy E McCart Reed, Malcolm Lim, Xavier M De Luca, Kaltin Ferguson, Colleen Niland, Roberta Mazzieri, Riccardo Dolcetti, Peter Thomas Simpson, Sunil R Lakhani
Characterization of Immune Cell Subsets of Tumor Infiltrating Lymphocytes in Brain Metastases. Biology 10 (5) (2021)
Valli De Re, Maria Lina Tornesello, Mariangela De Zorzi, Laura Caggiari, Francesca Pezzuto, Patrizia Leone, Vito Racanelli, Gianfranco Lauletta, Stefania Zanussi, Ombretta Repetto, Laura Gragnani, Francesca Maria Rossi, Riccardo Dolcetti, Anna Linda Zignego, Franco Maria Buonaguro, Agostino Steffan
PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus-related diseases. Liver international : official journal of the International Association for the Study of the Liver 41 (1) (2021)
Martina Proctor, Jazmina L G Cruz, Sheena M Daignault-Mill, Margaret Veitch, Bijun Zeng, Anna Ehmann, Muhammed Sabdia, Cameron E Snell, Colm Keane, Riccardo Dolcetti, Nikolas K Haass, James W Wells, Brian G Gabrielli
Targeting Replication Stress Using CHK1 Inhibitor Promotes Innate and NKT Cell Immune Responses and Tumour Regression. Cancers 13 (15) (2021)
Jack D Chan, Bianca von Scheidt, Bijun Zeng, Amanda J Oliver, Ashleigh S Davey, Aesha I Ali, Ranjeny Thomas, Joseph A Trapani, Phillip K Darcy, Michael H Kershaw, Riccardo Dolcetti, Clare Y Slaney
Enhancing chimeric antigen receptor T-cell immunotherapy against cancer using a nanoemulsion-based vaccine targeting cross-presenting dendritic cells. Clinical & translational immunology 9 (7) (2020)
Hui Yi Chew, Victor Chan, Fiona Simpson, Riccardo Dolcetti
Will Next-Generation Immunotherapy Overcome the Intrinsic Diversity and Low Immunogenicity of Sarcomas to Improve Clinical Benefit? Cancers 12 (11) (2020)
Hui Yi Chew, Riccardo Dolcetti, Fiona Simpson
Scientifically based combination therapies with immuno-oncology checkpoint inhibitors. British journal of clinical pharmacology 86 (9) (2020)
Cinzia Giagulli, Francesca Caccuri, Simone Zorzan, Antonella Bugatti, Alberto Zani, Federica Filippini, Ekta Manocha, Pasqualina D'Ursi, Alessandro Orro, Riccardo Dolcetti, Arnaldo Caruso
B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation. Cancer gene therapy 28 (6) (2020)
Malcolm Lim, Simon Puttick, Zachary H Houston, Kristofer J Thurecht, Priyakshi Kalita-de Croft, Stephen Mahler, Stephen E Rose, Rosalind L Jeffree, Roberta Mazzieri, Riccardo Dolcetti, Sunil R Lakhani, Jodi Marie Saunus
Innovative Therapeutic Strategies for Effective Treatment of Brain Metastases. International journal of molecular sciences 20 (6) (2019)
Pui Yeng Lam, Takumi Kobayashi, Megan S F Soon, Bijun Zeng, Riccardo Dolcetti, Graham Robert Leggatt, Ranjeny Thomas, Stephen R Mattarollo
NKT Cell-Driven Enhancement of Antitumor Immunity Induced by Clec9a-Targeted Tailorable Nanoemulsion. Cancer immunology research 7 (6) (2019)
Lara Alessandrini, Melissa Manchi, Valli De Re, Riccardo Dolcetti, Vincenzo Canzonieri
Proposed Molecular and miRNA Classification of Gastric Cancer. International journal of molecular sciences 19 (6) (2018)
Riccardo Dolcetti, Valli De Re, Vincenzo Canzonieri
Immunotherapy for Gastric Cancer: Time for a Personalized Approach? International journal of molecular sciences 19 (6) (2018)
Francesca Caccuri, Elena Muraro, Annunziata Gloghini, Ombretta Turriziani, Mara Riminucci, Cinzia Giagulli, Katy Mastorci, Damiana Antonia Fae', Simona Fiorentini, Antonino Caruso, Arnaldo Carbone, Riccardo Dolcetti
Lymphomagenic properties of a HIV p17 variant derived from a splenic marginal zone lymphoma occurred in a HIV-infected patient. Hematological oncology 37 (2) (2018)
Annunziata Gloghini, Chiara C Volpi, Ambra V Gualeni, Riccardo Dolcetti, Italia Bongarzone, Paolo De Paoli, Antonino Carbone
Multiple viral infections in primary effusion lymphoma: a model of viral cooperation in lymphomagenesis. Expert review of hematology 10 (6) (2017)

Riccardo Dolcetti.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Riccardo Dolcetti